Department of Pediatrics and Children's Diabetology, Medical University of Silesia, Katowice, Poland.
Pediatr Endocrinol Diabetes Metab. 2021;27(2):117-122. doi: 10.5114/pedm.2020.101809.
Autoimmune thyroid diseases (AIT) are one of the most common disorders associated with type 1 diabetes (T1D) and they are capable of influencing its course. For Hashimoto's lymphocytic thyroiditis, the incidence is 14-28%, while for Graves-Basedow hyperthyroidism it is 0.5-7%. Aim of the study: Assessment of type 1 diabetes in the pediatric population with coexisting autoimmune thyroid diseases: Hashimoto's lymphocytic thyroiditis and Graves-Basedow's disease.
Analyzing publications from the PubMed scientific database from 1990 to May 2020.
Among pediatric patients with T1D and coexisting thyroid autoimmunity insufficient glycemic control is usually observed. Reported average increase in glycated hemoglobin concentration ranges from 7.9 to 9.2%. In children with T1D and subclinical hypothyroidism, an increased number of episodes of hypoglycemia was noted - 5 vs. 2 episodes per year among children with euthyroidism. In hyperthyroidism patients the number of episodes of hypoglycemia was 34.4 vs. 17.2 per 100 incidents in euthyroidism patients. An increased occurrence of diabetic ketoacidosis events may also be observed - 18.1 vs. 7.7 per 100 patients with euthyroidism per year. The risk of developing chronic complications in the form of cardiovascular diseases is also higher. However, basing on the available literature, this subject is still debatable.
Autoimmune thyroid diseases often accompany and interfere with type 1 diabetes in children and adolescents. Paying special attention to the different course of diabetes in the presence of thyroid disorders is an important and essential element of diabetes care.
自身免疫性甲状腺疾病(AIT)是与 1 型糖尿病(T1D)相关的最常见疾病之一,它们能够影响其病程。桥本甲状腺炎的发病率为 14-28%,而格雷夫斯病的发病率为 0.5-7%。目的:评估儿科人群中同时存在的自身免疫性甲状腺疾病(桥本甲状腺炎和格雷夫斯病)对 1 型糖尿病的影响。
分析了 1990 年至 2020 年 5 月期间 PubMed 科学数据库中的出版物。
在患有 T1D 和并存甲状腺自身免疫的儿科患者中,通常观察到血糖控制不足。报告的糖化血红蛋白浓度平均增加范围为 7.9 至 9.2%。在 T1D 合并亚临床甲状腺功能减退症的儿童中,低血糖发作次数增加,分别为每年 5 次和甲状腺功能正常的儿童每年 2 次。在甲状腺功能亢进症患者中,低血糖发作次数为 34.4 次/100 例,甲状腺功能正常的患者为 17.2 次/100 例。还可能观察到糖尿病酮症酸中毒事件的发生率增加-每年每 100 例甲状腺功能正常的患者中分别为 18.1 次和 7.7 次。发生心血管疾病等慢性并发症的风险也更高。然而,基于现有文献,这个问题仍存在争议。
自身免疫性甲状腺疾病常与儿童和青少年的 1 型糖尿病并存并相互干扰。特别关注甲状腺疾病存在时糖尿病的不同病程是糖尿病护理的一个重要和必要的组成部分。